Marcel A Behr Selected Research

Marcel A Behr Research Topics

Disease

31	Tuberculosis (Tuberculoses) 01/2022 - 01/2002
26	Infections 06/2022 - 02/2003
5	Crohn Disease (Crohn's Disease) 01/2013 - 01/2008
3	COVID-19 01/2022 - 01/2021
3	Paratuberculosis (Johne's Disease) 12/2015 - 01/2008
2	Cerebral Malaria 01/2020 - 01/2012
2	Pulmonary Tuberculosis 04/2019 - 01/2018
2	autosomal recessive Candidiasis familial chronic mucocutaneous 04/2016 - 07/2014
2	Candidiasis (Moniliasis) 04/2016 - 07/2014
1	Vaccine-Preventable Diseases 01/2022
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022
1	Common Cold 01/2022
1	Bovine Tuberculosis 01/2022
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2021
1	Persistent Infection 10/2020
1	Cough 01/2020
1	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2020
1	Neuroinflammatory Diseases 01/2020
1	Latent Tuberculosis 01/2020
1	Lymphoma (Lymphomas) 04/2016
1	Mycoses (Diseases, Fungus) 04/2016
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 04/2016
1	Lymphatic Diseases 03/2014
1	Clostridium Infections 06/2013
1	Vitamin D Deficiency 01/2013
1	Hypoxia (Hypoxemia) 12/2010
1	Gastroenteritis 05/2010
1	Confusion (Bewilderment) 02/2002

Drug/Important Bio-Agent (IBA)

15	VaccinesIBA 06/2022 - 01/2002
7	Proteins (Proteins, Gene)FDA Link 01/2020 - 02/2005
6	DNA (Deoxyribonucleic Acid)IBA 11/2015 - 01/2004
5	CytokinesIBA 01/2022 - 11/2008
4	AntigensIBA 02/2021 - 09/2006
3	Tuberculin (PPD)IBA 01/2022 - 09/2006
3	Attenuated VaccinesIBA 01/2022 - 09/2007
3	AerosolsIBA 02/2021 - 11/2008
3	IronIBA 10/2020 - 11/2013
3	Indicators and Reagents (Reagents)IBA 01/2020 - 09/2006
3	Biological ProductsIBA 06/2011 - 09/2005
2	LipidsIBA 10/2020 - 01/2020
2	1-tuberculosinyladenosineIBA 10/2020 - 01/2019
2	Ethylnitrosourea (N-Ethyl-N-nitrosourea)IBA 01/2020 - 01/2012
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 04/2016 - 07/2014
2	Peptidoglycan (Murein)IBA 02/2015 - 07/2009
2	Vitamin D FDA LinkGeneric 01/2013 - 07/2010
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2021
1	Clarithromycin (Biaxin)FDA LinkGeneric 10/2021
1	RNA (Ribonucleic Acid)IBA 10/2021
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2021
1	Interleukin-12 (IL 12)IBA 01/2021
1	Pattern Recognition ReceptorsIBA 01/2021
1	Virulence Factors (Pathogenicity Factors)IBA 10/2020
1	Levofloxacin (Levaquin)FDA Link 01/2020
1	1,2-dihydroxy-4-(nitroethenyl)benzene (SL-1)IBA 01/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	AntibodiesIBA 04/2019
1	Tuberculosis VaccinesIBA 01/2018
1	BCG Vaccine FDA Link 01/2018
1	Transcription Factors (Transcription Factor)IBA 12/2016
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 12/2016
1	ras-GRF1 (ras GRF1)IBA 04/2016
1	SiderophoresIBA 12/2015
1	mycobactinsIBA 12/2015
1	Aryl Hydrocarbon Receptor Nuclear TranslocatorIBA 11/2015
1	Tryptophan (L-Tryptophan)FDA Link 11/2015
1	EnzymesIBA 11/2015
1	VitaminsIBA 08/2015
1	CarbohydratesIBA 08/2015
1	Heparin (Liquaemin)FDA LinkGeneric 11/2013
1	heparin-sepharoseIBA 11/2013
1	heparin-binding hemagglutininIBA 11/2013
1	Proton Pump InhibitorsIBA 06/2013
1	InterleukinsIBA 01/2013
1	ChemokinesIBA 01/2013
1	1,25-dihydroxyvitamin DIBA 01/2013
1	Phosphotransferases (Kinase)IBA 01/2012
1	Interferon-gamma (Interferon, gamma)IBA 01/2012
1	EpitopesIBA 12/2010
1	Phenobarbital (Luminal)FDA Link 05/2010
1	Calcitriol (Calcijex)FDA LinkGeneric 01/2010
1	DefensinsIBA 01/2010
1	Genetic Markers (Genetic Marker)IBA 10/2009
1	Toll-Like Receptors (Toll-Like Receptor)IBA 07/2009
1	Interferon Type IIBA 07/2009

Therapy/Procedure

5	Therapeutics 07/2014 - 01/2008
1	N95 Respirators 01/2022
1	Mechanical Ventilators (Ventilator) 01/2022
1	Duration of Therapy 11/2021
1	Breast Implants (Breast Implant) 11/2018
1	Prostheses and Implants (Prosthesis) 11/2018